Moroctocog alfa

N/A

Report date: 2023/03/17 09:06:45

Base Information

Drug NameMoroctocog alfa
Drug Alias Name重组莫凝血素-8αFuseNGORecombinant factor VIII SQ重组莫罗凝血素重组莫罗凝血素/抗血友病因子 +[25] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant coagulation factor
Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsHemophilia A
Approved Indications in ChinaHemophilia A
Original Approved Country/TerritoryEU
Original Approved Date1999/04/13
Country/TerritoryBulgariaUnited StatesSweden +[12] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Europe Ma Eeig
Inactive CompaniesWyeth LlcPfizer IncSinoCelltech Ltd
Active IndicationsHemophilia A
Inactive IndicationsN/A

Other Information

ATC CodeB02BD02
Related LinksWikipediaDrugBankKEGG